ASTRAZENECA PLC (AZN)
Clinical trial NCT06097728 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2027-11-19 → 2028-11-16 3. enrollment: 825 → 861 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06097728 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2027-11-19 → 2028-11-16 3. enrollment: 825 → 861 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical